During the transition period, EU pharmaceutical law as laid out in the ‘Acquis Communautaire’ is applicable to the UK.

Companies have been reminded to make all the necessary changes to ensure that their authorized medicines comply with EU law and can remain on the EU market after the 31 December 2020. 

Oppdatert: 18.12.2020

Publisert: 23.04.2019

​Fant du det du lette etter?